Daniel Hart's most recent trade in Avid Bioservices Inc was a trade of 1,755 Common Stock, $0.001 par value done at an average price of $6.1 . Disclosure was reported to the exchange on Dec. 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 6.05 per share. | 31 Dec 2024 | 1,755 | 112,735 (0%) | 0% | 6.1 | 10,621 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Hart Daniel Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Dec 2024 | 45,328 | 133,793 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Ryan Daniel Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 22,818 | 116,816 | - | - | Performance Stock Units (FY 2025 Grant) | |
| Avid Bioservices Inc | Ryan Daniel Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 22,817 | 139,634 | - | - | Performance Stock Units (FY 2025 Grant) | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 25 Dec 2024 | 20,845 | 110,980 (0%) | 0% | 12.2 | 254,726 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Hart Ryan | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,304 | 162,451 | - | - | Performance Stock Units (FY 2024 Grant) | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,303 | 173,755 | - | - | Performance Stock Units (FY 2024 Grant) | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,208 | 185,058 | - | - | Performance Stock Units (FY 2023 Grant) | |
| Avid Bioservices Inc | Daniel Hart Ryan | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 11,208 | 196,266 | - | - | Performance Stock Units (FY 2023 Grant) | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 4,279 | 123,096 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Dec 2024 | 4,279 | 88,465 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Hart Ryan Daniel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 25 Dec 2024 | 1,968 | 131,825 (0%) | 0% | 12.2 | 24,049 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 136,905 | 265,773 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 68,452 | 127,375 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 5.41 per share. | 28 Jun 2024 | 1,965 | 84,186 (0%) | 0% | 5.4 | 10,623 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 30 Apr 2024 | 2,826 | 82,221 (0%) | 0% | 7.4 | 20,910 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,120 | 85,047 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,120 | 58,923 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,102 | 61,043 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 2,102 | 82,927 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,520 | 80,825 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,520 | 63,145 | - | - | Restricted Stock Units | |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.59 per share. | 02 Mar 2024 | 1,471 | 216,140 (0%) | 0% | 124.6 | 183,272 | Common Stock |
| Crocs Inc | Daniel Hart | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Mar 2024 | 1,393 | 217,900 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.59 per share. | 02 Mar 2024 | 289 | 217,611 (0%) | 0% | 124.6 | 36,007 | Common Stock |
| Crocs Inc | Hart Daniel | Executive Vice President | Sale of securities on an exchange or to another person at price $ 118.48 per share. | 23 Feb 2024 | 10,000 | 219,293 (0%) | 0% | 118.5 | 1,184,823 | Common Stock |
| Avid Bioservices Inc | Hart Ryan Daniel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 09 Jan 2024 | 2,408 | 79,305 (0%) | 0% | 6.2 | 14,857 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Ryan Hart Daniel | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,119 | 64,665 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Hart Daniel Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,119 | 81,713 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,101 | 66,784 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Ryan Daniel Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 2,101 | 79,594 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Hart Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,520 | 68,885 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Hart Daniel Ryan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,520 | 77,493 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 5.52 per share. | 29 Dec 2023 | 892 | 75,973 (0%) | 0% | 5.5 | 4,928 | Common Stock, $0.001 par value |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.47 per share. | 17 Aug 2023 | 1,695 | 229,293 (0%) | 0% | 92.5 | 156,737 | Common Stock |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.77 per share. | 03 Aug 2023 | 1,988 | 230,988 (0%) | 0% | 103.8 | 206,295 | Common Stock |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.66 per share. | 22 Jul 2023 | 1,130 | 232,976 (0%) | 0% | 122.7 | 138,606 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 10,723 | 75,143 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 5,867 | 76,146 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2023 | 4,856 | 82,013 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 10 Jul 2023 | 3,763 | 71,380 (0%) | 0% | 13.9 | 52,153 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 67,822 | 128,868 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 33,911 | 90,490 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 3,621 | 65,689 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2023 | 2,101 | 88,389 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2023 | 1,520 | 86,869 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.77 per share. | 09 Jul 2023 | 1,269 | 64,420 (0%) | 0% | 13.8 | 17,475 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 11.46 per share. | 30 Jun 2023 | 927 | 62,068 (0%) | 0% | 11.5 | 10,622 | Common Stock, $0.001 par value |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.74 per share. | 26 May 2023 | 1,131 | 234,106 (0%) | 0% | 106.7 | 120,723 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 2,102 | 56,579 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 2,102 | 49,829 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 1,520 | 47,727 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2023 | 1,520 | 58,681 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.80 per share. | 09 Apr 2023 | 1,280 | 48,549 (0%) | 0% | 19.8 | 25,340 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 14 Mar 2023 | 3,000 | 46,957 (0%) | 0% | 19 | 57,000 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 14 Mar 2023 | 2,000 | 46,957 (0%) | 0% | 19 | 38,000 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.66 per share. | 14 Mar 2023 | 2,000 | 48,957 (0%) | 0% | 5.7 | 11,320 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 2,000 | 230,380 | - | - | Stock Option(right to buy) | |
| Crocs Inc | Daniel Hart | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 6,726 | 244,086 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Daniel Hart | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Mar 2023 | 4,400 | 239,686 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.06 per share. | 02 Mar 2023 | 2,944 | 235,237 (0%) | 0% | 125.1 | 368,177 | Common Stock |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.54 per share. | 02 Mar 2023 | 1,505 | 238,181 (0%) | 0% | 125.5 | 188,938 | Common Stock |
| Crocs Inc | Daniel Hart | Executive Vice President | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 11 Jan 2023 | 10,000 | 237,360 (0%) | 0% | 120 | 1,200,000 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 2,101 | 51,456 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 2,101 | 60,201 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 1,520 | 62,302 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 1,520 | 49,355 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.44 per share. | 09 Jan 2023 | 1,499 | 49,957 (0%) | 0% | 14.4 | 21,647 | Common Stock, $0.001 par value |
| Crocs Inc | Daniel Hart | Executive Vice President | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 03 Jan 2023 | 10,000 | 247,360 (0%) | 0% | 110 | 1,100,000 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Other type of transaction at price $ 11.70 per share. | 30 Dec 2022 | 815 | 47,835 (0%) | 0% | 11.7 | 9,539 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 2,101 | 48,282 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 2,101 | 63,822 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 1,520 | 46,181 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2022 | 1,520 | 65,923 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.90 per share. | 09 Oct 2022 | 1,262 | 47,020 (0%) | 0% | 17.9 | 22,590 | Common Stock, $0.001 par value |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Aug 2022 | 1,701 | 257,360 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Aug 2022 | 1,995 | 259,061 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 22 Jul 2022 | 1,133 | 261,056 (0%) | 0% | 0 | Common Stock | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2022 | 67,247 | 99,675 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2022 | 33,623 | 79,685 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 5,866 | 44,129 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 5,866 | 72,299 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 4,856 | 48,985 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 4,856 | 67,443 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 09 Jul 2022 | 4,324 | 44,661 (0%) | 0% | 17.8 | 76,768 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 1,520 | 38,263 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2022 | 1,520 | 78,165 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 11,673 | 36,968 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 11,673 | 40,893 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jul 2022 | 4,540 | 32,428 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.53 per share. | 07 Jul 2022 | 4,150 | 36,743 (0%) | 0% | 17.5 | 72,758 | Common Stock, $0.001 par value |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.28 per share. | 26 May 2022 | 1,133 | 262,189 (0%) | 0% | 53.3 | 60,366 | Common Stock |
| Crocs Inc | Daniel Hart | Executive Vice President | Purchase of securities on an exchange or from another person at price $ 52.63 per share. | 10 May 2022 | 5,000 | 263,322 (0%) | 0% | 52.6 | 263,145 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2022 | 1,520 | 46,062 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2022 | 1,520 | 29,496 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.56 per share. | 09 Apr 2022 | 726 | 28,770 (0%) | 0% | 18.6 | 13,476 | Common Stock, $0.001 par value |
| Crocs Inc | Daniel Hart | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 9,950 | 261,405 (0%) | 0% | 0 | Common Stock | |
| Crocs Inc | Daniel Hart | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.44 per share. | 03 Mar 2022 | 3,083 | 258,322 (0%) | 0% | 67.4 | 207,918 | Common Stock |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2022 | 1,520 | 28,853 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.58 per share. | 09 Jan 2022 | 877 | 27,976 (0%) | 0% | 21.6 | 18,925 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Daniel Ryan Hart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2022 | 520 | 47,582 | - | - | Restricted Stock Units |